Skip to content

Clinical trials

Thrombocythemia, Essential trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Denmark Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20122
20131
20181
20191
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Inge Marie Svane2
Copenhagen University Hospital at Herlev1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Shire1
Thomas Stauffer Larsen1
University of Southern Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential9
Polycythemia Vera5
Primary Myelofibrosis5
Myeloproliferative Disorders3
Hematologic Diseases2
Blood Coagulation Disorders1
Blood Platelet Disorders1
Bone Marrow Diseases1
Fractures, Bone1
Hemorrhagic Disorders1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.